Inflammatory Response Research, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Inflammatory Response Research, Inc..The latest application filed is for "use of levocetirizine and montelukast in the treatment of traumatic injury".

Company Profile

5.15.14

Inflammatory Response Research, Inc. - Santa Barbara CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Levocetirizine And Montelukast In The Treatment Of Traumatic Injury App 20220096465 - May; Bruce Chandler	2022-03-31
Use of levocetirizine and montelukast in the treatment of traumatic injury Grant 11,103,500 - May August 31, 2	2021-08-31
Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure Grant 10,537,568 - May Ja	2020-01-21
Use of levocetirizine and montelukast in the treatment of vasculitis Grant 10,206,919 - May Feb	2019-02-19
Use of levocetirizine and montelukast in the treatment of autoimmune disorders Grant 10,201,537 - May Feb	2019-02-12
Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant 10,195,193 - May Fe	2019-02-05
Use Of Levocetirizine And Montelukast In The Treatment Of Traumatic Injury App 20180185357 - May; Bruce Chandler	2018-07-05
Levocetirizine And Montelukast In The Treatment Of Inflammation Mediated Conditions App 20180169091 - May; Bruce Chandler	2018-06-21
Use of levocetirizine and montelukast in the treatment of traumatic injury Grant 9,937,166 - May April 10, 2	2018-04-10
Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant 9,925,183 - May March 27, 2	2018-03-27
Use Of Levocetirizine And Montelukast In The Treatment Of Anaphylaxis App 20170368059 - May; Bruce Chandler	2017-12-28
Use Of Levocetirizine And Montelukast In The Treatment Of Autoimmune Disorders App 20170296534 - May; Bruce Chandler	2017-10-19
Use Of Levocetirizine And Montelukast In The Treatment Of Vasculitis App 20170231980 - May; Bruce Chandler	2017-08-17
Levocetirizine And Montelukast In The Treatment Of Inflammation Mediated Conditions App 20170173001 - May; Bruce Chandler	2017-06-22
Use of levocetirizine and montelukast in the treatment of autoimmune disorders Grant 9,669,026 - May June 6, 2	2017-06-06
Use of levocetirizine and montelukast in the treatment of vasculitis Grant 9,669,025 - May June 6, 2	2017-06-06
Use Of Levocetirizine And Montelukast In The Treatment Of Traumatic Injury App 20170056395 - May; Bruce Chandler	2017-03-02
Use of levocetirizine and montelukast in the treatment of traumatic injury Grant 9,522,148 - May December 20, 2	2016-12-20
Use Of Levocetirizine And Montelukast To Ameliorate Inflammation Following Radiation Exposure App 20160175301 - May; Bruce Chandler	2016-06-23
Use Of Levocetirizine And Montelukast In The Treatment Of Anaphylaxis App 20150352102 - May; Bruce Chandler	2015-12-10
Use Of Levocetirizine And Montelukast In The Treatment Of Traumatic Injury App 20150352104 - May; Bruce Chandler	2015-12-10
Use Of Levocetirizine And Montelukast In The Treatment Of Autoimmune Disorders App 20150352103 - May; Bruce Chandler	2015-12-10
Use Of Levocetirizine And Montelukast In The Treatment Of Vasculitis App 20150352101 - May; Bruce Chandler	2015-12-10
Use Of Levocetirizine And Montelukast In The Treatment Of Influenza, Common Cold And Inflammation App 20150231133 - May; Bruce Chandler	2015-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.